Financial statements Same Dobre Apteki Pharm
Balance sheet data of SAME DOBRE APTEKI PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 13 361 659,31 | 14 903 847,59 | 19 373 446,75 | 21 818 437,51 | 21 586 822,19 | 24 710 484,83 |
| A. Fixed assets | 8 346 121,88 | 10 968 566,61 | 13 836 966,50 | 13 690 723,56 | 17 818 552,29 | 14 624 407,14 |
| B. Current assets | 5 015 537,43 | 3 935 280,98 | 5 536 480,25 | 8 127 713,95 | 3 768 269,90 | 10 086 077,69 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 13 361 659,31 | 14 903 847,59 | 19 373 446,75 | 21 818 437,51 | 21 586 822,19 | 24 710 484,83 |
| A. Equity | 6 959 857,07 | 9 535 038,04 | 12 185 467,31 | 15 021 741,81 | 17 491 398,85 | 19 247 348,55 |
| B. Liabilities and provisions for liabilities | 6 401 802,24 | 5 368 809,55 | 7 187 979,44 | 6 796 695,70 | 4 095 423,34 | 5 463 136,28 |
| I. Long-term liabilities | 3 815 843,52 | 3 095 257,89 | 6 146 874,10 | 5 445 033,05 | 2 644 850,00 | 2 644 850,00 |
| II. Short-term liabilities | 2 585 958,72 | 2 273 551,66 | 1 041 105,34 | 1 351 662,65 | 1 450 573,34 | 2 818 286,28 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.